Jennifer Hollywood, PhD, University College Cork, Ireland, and Alan Davidson, PhD, University of Auckland, New Zealand
Drs. Hollywood and Davidson are using rodent models to test a better variant of cysteamine and to find alternative therapies that target other pathways to improve the lives of patients with cystinosis. Since 2020, CRF has awarded $430,422 to Dr. Jennifer Hollywood and her team for a study to test a new version of cysteamine. If this works, the latest drug combination could mean less frequent dosing, a reduction in gastrointestinal side effects, and perhaps prevent or delay the need for a kidney transplant. With CRF leading the way, there is hope for an improved treatment for our patient community!
Read more about the study: Research Update and Research Study Lay Abstract
